Doctor, doctor, give me the news, Hims & Hers Health (HIMS) has got bad case of the stock market blues. The San Francisco ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

Surgeons are removing up to 10 kilograms of excess skin from patients who have lost major amounts of weight, amid a booming interest in body-contouring operations.

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

Shares of Hims & Hers (HIMS) are down $3.47, or 8%, to $37.50 in pre-market trading after a court denied a motion for a preliminary ...

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

This shortage is the essential thing permitting drug compounders like OFA (and Hims & Hers Health, too) to make and sell ...

President Donald Trump’s pick to lead the Food and Drug Administration is set to answer Senate questions Thursday about his ...